-
-
-
-
-
-
-
Trinity Biotech Announces Successful Clinical Results for Its Enhanced EpiCapture™ Prostate Cancer Test
-
-
-
-
-
-
-
Trinity Biotech Announces Further Major Technical Breakthroughs in Advancing Next Generation CGM+ PlatformÂ
-
-
-
-
-
-
-
Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares
-
-
-
-
-
-
-
Trinity Biotech secures funding agreements with Perceptive Advisors
-
-
-
-
-
-
-
Trinity Biotech Secures Major Regulatory Approval for Offshored and Outsourced Manufacturing of Its Market Leading Uni-Gold Rapid HIV Test, Further Accelerating Financial Performance Transformation
-
-
-
-
-
-
-
Trinity Biotech gets approval to offer preeclampsia test in New York
-
-
-
-
-
-
-
Trinity Biotech unveils CGM+ wearable biosensor for AI health market
-
1,161,909 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

